Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $90.8 million.

  • Cellebrite DI's Free Cash Flow rose 3127.05% to $90.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $186.8 million, marking a year-over-year increase of 3270.78%. This contributed to the annual value of $186.8 million for FY2025, which is 3270.78% up from last year.
  • According to the latest figures from Q4 2025, Cellebrite DI's Free Cash Flow is $90.8 million, which was up 3127.05% from $36.6 million recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Free Cash Flow ranged from a high of $90.8 million in Q4 2025 and a low of -$10.7 million during Q1 2022
  • Moreover, its 5-year median value for Free Cash Flow was $20.3 million (2023), whereas its average is $24.6 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 359204.15% in 2022, then skyrocketed by 486535.43% in 2023.
  • Cellebrite DI's Free Cash Flow (Quarter) stood at $29.0 million in 2021, then grew by 27.86% to $37.1 million in 2022, then rose by 24.11% to $46.1 million in 2023, then skyrocketed by 50.03% to $69.1 million in 2024, then surged by 31.27% to $90.8 million in 2025.
  • Its Free Cash Flow stands at $90.8 million for Q4 2025, versus $36.6 million for Q3 2025 and $36.2 million for Q2 2025.